Studies of Glucocorticoid Induced Hyperglycaemia - Part 1: effects of commonly prescribed Glucocorticoid (GC) regimens on blood sugar levels

Continuous glucose monitoring to profile the effects of Glucocorticoid regimens on glycaemia.

Status

Not yet recruiting

Phases

Unknown

Study type

Observational

Source

ANZCTR

Registry ID

ACTRN12616001692426

Enrollment

Registered

2016-12-08

Start date

2016-12-12

Completion date

2018-12-31

Last updated

2020-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

To use continuous glucose monitoring (CGM) to profile the glycemic impact of commonly prescribed GC regimens.

Interventions

To use continuous glucose monitoring (CGM) to profile the glycemic impact of commonly prescribed Glucocorticoid (GC) regimens. CGM will be applied for 3 days prior to the first dose of GC and continued for 3 days following GC administration at per the prescribed dose frequency (total duration 6 days)

Eligibility

Sex/Gender

All

Age

18 Years to 90 Years

Healthy volunteers

Inclusion criteria

Patients with and without diabetes who are planned to have glucocorticoids for a medical indication.

Exclusion criteria

Subjects under the age of 18, subjects whose primary language is other than English, subjects with a cognitive impairment, an intellectual disability or a mental illness

Outcome results